Share-based Payment Arrangement, Expense of Molecular Templates, Inc. from 31 Dec 2010 to 30 Jun 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Molecular Templates, Inc. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Dec 2010 to 30 Jun 2024.
  • Molecular Templates, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Jun 2024 was $722,000, a 60% decline year-over-year.
  • Molecular Templates, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Jun 2024 was $4,416,000, a 53% decline year-over-year.
  • Molecular Templates, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $6,702,000, a 44% decline from 2022.
  • Molecular Templates, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11,909,000, a 28% decline from 2021.
  • Molecular Templates, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $16,631,000, a 41% increase from 2020.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Molecular Templates, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2024 $4,416,000 $722,000 -$1,062,000 -60% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $5,478,000 $1,086,000 -$1,224,000 -53% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $6,702,000 $1,360,000 -$1,244,000 -48% 01 Oct 2023 31 Dec 2023 10-K 29 Mar 2024 2023 FY
Q3 2023 $7,946,000 $1,248,000 -$1,393,000 -53% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $9,339,000 $1,784,000 -$1,198,000 -40% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $10,537,000 $2,310,000 -$1,372,000 -37% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024 2024 Q1
Q4 2022 $11,909,000 $2,604,000 -$1,205,000 -32% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
Q3 2022 $13,114,000 $2,641,000 -$1,602,000 -38% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023 2023 Q3
Q2 2022 $14,716,000 $2,982,000 -$1,531,000 -34% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 $16,247,000 $3,682,000 -$384,000 -9.4% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $16,631,000 $3,809,000 +$519,000 +16% 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $16,112,000 $4,243,000 +$958,000 +29% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $15,154,000 $4,513,000 +$1,463,000 +48% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022 2022 Q2
Q1 2021 $13,691,000 $4,066,000 +$1,874,000 +85% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 $11,817,000 $3,290,000 +$1,761,000 +115% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $10,056,000 $3,285,000 +$1,758,000 +115% 01 Jul 2020 30 Sep 2020 10-Q 15 Nov 2021 2021 Q3
Q2 2020 $8,298,000 $3,050,000 +$1,608,000 +112% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021 2021 Q2
Q1 2020 $6,690,000 $2,192,000 +$831,000 +61% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021 2021 Q1
Q4 2019 $5,859,000 $1,529,000 +$299,000 +24% 01 Oct 2019 31 Dec 2019 10-K 19 Mar 2021 2020 FY
Q3 2019 $5,560,000 $1,527,000 +$330,000 +28% 01 Jul 2019 30 Sep 2019 10-Q 06 Nov 2020 2020 Q3
Q2 2019 $5,230,000 $1,442,000 +$520,000 +56% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $4,710,000 $1,361,000 +$718,000 +112% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q4 2018 $3,992,000 $1,230,000 +$867,000 +239% 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
Q3 2018 $3,125,000 $1,197,000 -$181,000 -13% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $3,306,000 $922,000 +$897,000 +3588% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019 2019 Q2
Q1 2018 $2,409,000 $643,000 +$617,000 +2373% 01 Jan 2018 31 Mar 2018 10-Q 13 May 2019 2019 Q1
Q4 2017 $1,792,000 $363,000 +$1,926,000 01 Oct 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
Q3 2017 $134,000 $1,378,000 +$1,351,000 +5004% 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $1,485,000 $25,000 -$777,000 -97% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q2
Q1 2017 $708,000 $26,000 -$817,000 -97% 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1
Q4 2016 $109,000 $1,563,000 -$3,572,000 -178% 01 Oct 2016 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q3 2016 $3,681,000 $27,000 -$1,449,000 -98% 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 $5,130,000 $802,000 -$1,093,000 -58% 01 Apr 2016 30 Jun 2016 10-Q 31 Jul 2017 2017 Q2
Q1 2016 $6,223,000 $843,000 -$578,000 -41% 01 Jan 2016 31 Mar 2016 10-Q 15 May 2017 2017 Q1
Q4 2015 $6,801,000 $2,009,000 -$3,391,000 -63% 01 Oct 2015 31 Dec 2015 10-K 27 Mar 2017 2016 FY
Q3 2015 $10,192,000 $1,476,000 +$278,000 +23% 01 Jul 2015 30 Sep 2015 10-Q 07 Nov 2016 2016 Q3
Q2 2015 $9,914,000 $1,895,000 +$427,000 +29% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016 2016 Q2
Q1 2015 $9,487,000 $1,421,000 +$155,000 +12% 01 Jan 2015 31 Mar 2015 10-Q 05 May 2016 2016 Q1
Q4 2014 $5,400,000 +$600,000 +12% 30 Dec 2014 31 Dec 2014 10-K 03 Mar 2015 2014 FY
Q3 2014 $8,732,000 $1,198,000 -$33,000 -2.7% 01 Jul 2014 30 Sep 2014 10-Q 02 Nov 2015 2015 Q3
Q2 2014 $8,765,000 $1,468,000 +$196,000 +15% 01 Apr 2014 30 Jun 2014 10-Q 30 Jul 2015 2015 Q2
Q1 2014 $8,569,000 $1,266,000 +$213,000 +20% 01 Jan 2014 31 Mar 2014 10-Q 30 Apr 2015 2015 Q1
Q4 2013 $4,800,000 +$2,000,000 +71% 30 Dec 2013 31 Dec 2013 10-K 03 Mar 2015 2014 FY
Q3 2013 $6,356,000 $1,231,000 +$287,000 +30% 01 Jul 2013 30 Sep 2013 10-Q 03 Nov 2014 2014 Q3
Q2 2013 $6,069,000 $1,272,000 +$528,000 +71% 01 Apr 2013 30 Jun 2013 10-Q 01 Aug 2014 2014 Q2
Q1 2013 $5,541,000 $1,053,000 +$655,000 +165% 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014 2014 Q1
Q4 2012 $2,800,000 30 Dec 2012 31 Dec 2012 10-K 03 Mar 2015 2014 FY
Q3 2012 $944,000 +$652,000 +223% 01 Jul 2012 30 Sep 2012 10-Q 04 Nov 2013 2013 Q3
Q2 2012 $744,000 +$542,000 +268% 01 Apr 2012 30 Jun 2012 10-Q 01 Aug 2013 2013 Q2
Q1 2012 $398,000 01 Jan 2012 31 Mar 2012 10-Q 02 May 2013 2013 Q1
Q3 2011 $292,000 01 Jul 2011 30 Sep 2011 10-Q 02 Nov 2012 2012 Q3
Q2 2011 $202,000 01 Apr 2011 30 Jun 2011 10-Q 06 Aug 2012 2012 Q2

Molecular Templates, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $6,702,000 -$5,207,000 -44% 01 Jan 2023 31 Dec 2023 10-K 29 Mar 2024 2023 FY
2022 $11,909,000 -$4,722,000 -28% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024 2023 FY
2021 $16,631,000 +$4,814,000 +41% 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $11,817,000 +$5,958,000 +102% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022 2021 FY
2019 $5,859,000 +$1,867,000 +47% 01 Jan 2019 31 Dec 2019 10-K 19 Mar 2021 2020 FY
2018 $3,992,000 +$2,200,000 +123% 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020 2019 FY
2017 $1,792,000 +$1,683,000 +1544% 01 Jan 2017 31 Dec 2017 10-K 29 Mar 2019 2018 FY
2016 $109,000 -$6,692,000 -98% 01 Jan 2016 31 Dec 2016 10-K 30 Mar 2018 2017 FY
2015 $6,801,000 +$1,313,000 +24% 01 Jan 2015 31 Dec 2015 10-K 27 Mar 2017 2016 FY
2014 $5,488,000 +$566,000 +11% 01 Jan 2014 31 Dec 2014 10-K 27 Mar 2017 2016 FY
2013 $4,922,000 +$1,912,000 +64% 01 Jan 2013 31 Dec 2013 10-K 10 Mar 2016 2015 FY
2012 $3,010,000 +$1,971,000 +190% 01 Jan 2012 31 Dec 2012 10-K 03 Mar 2015 2014 FY
2011 $1,039,000 +$236,000 +29% 01 Jan 2011 31 Dec 2011 10-K 06 Mar 2014 2013 FY
2010 $803,000 01 Jan 2010 31 Dec 2010 10-K 07 Mar 2013 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.